Literature DB >> 18182455

A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance.

Virginie Mariot1, Stéphanie Maupetit-Méhouas, Christiane Sinding, Marie-Laure Kottler, Agnès Linglart.   

Abstract

CONTEXT: Pseudohypoparathyroidism (PHP) type Ia is a rare maternally transmitted disease due to maternal loss-of-function mutations of GNAS, the gene encoding Galphas, the alpha-stimulatory subunit of the G protein. Affected individuals display hormonal resistance (mainly PTH and TSH resistance) and Albright hereditary osteodystrophy. PHP type Ib (PHP-Ib), usually defined by isolated renal resistance to PTH and sometimes mild TSH resistance, is due to a maternal loss of GNAS exon A/B methylation, leading to decreased Galphas expression in specific tissues. OBJECTIVE AND
RESULTS: We report a girl with obvious Albright osteodystrophy features, PTH resistance, normal Galphas bioactivity in red blood cells, yet no loss-of-function mutation in the GNAS coding sequence (exons 1-13). The methylation analysis of the four GNAS differentially methylated regions, i.e. NESP, AS, XL, and A/B, revealed broad methylation changes at all differentially methylated regions, including GNAS exon A/B, leading to a paternal epigenotype on both alleles.
CONCLUSIONS: This observation suggests that: 1) the decreased expression of Galphas due to GNAS epimutations is not restricted to the renal tubule but may affect nonimprinted tissues like bone; 2) PHP-Ib is a heterogeneous disorder that should lead to studying GNAS epigenotype in patients with PHP and no mutation in GNAS exons 1-13, regardless of their physical features.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182455     DOI: 10.1210/jc.2007-0927

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  38 in total

1.  Recessive versus imprinted disorder: consanguinity can impede establishing the diagnosis of autosomal dominant pseudohypoparathyroidism type Ib.

Authors:  Serap Turan; Leyla Akin; Teoman Akcay; Erdal Adal; Sevil Sarikaya; Murat Bastepe; Harald Jüppner
Journal:  Eur J Endocrinol       Date:  2010-06-10       Impact factor: 6.664

2.  A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B.

Authors:  Monica Reyes; Anara Karaca; Murat Bastepe; Nese Ersoz Gulcelik; Harald Jüppner
Journal:  Bone       Date:  2017-07-12       Impact factor: 4.398

3.  Madelung-like deformity in pseudohypoparathyroidism type 1b.

Authors:  Janine Sanchez; Erasmo Perera; Suzanne Jan de Beur; Changlin Ding; Anna Dang; Gary D Berkovitz; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2011-07-13       Impact factor: 5.958

Review 4.  Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Authors:  Giovanna Mantovani; Anna Spada; Francesca Marta Elli
Journal:  Nat Rev Endocrinol       Date:  2016-04-22       Impact factor: 43.330

5.  Clinical utility gene card for: pseudohypoparathyroidism.

Authors:  Giovanna Mantovani; Agnes Linglart; Intza Garin; Caroline Silve; Francesca M Elli; Guiomar Perez de Nanclares
Journal:  Eur J Hum Genet       Date:  2012-09-12       Impact factor: 4.246

Review 6.  GNAS Spectrum of Disorders.

Authors:  Serap Turan; Murat Bastepe
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

7.  A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism.

Authors:  Sihoon Lee; Michael Mannstadt; Jun Guo; Seul Min Kim; Hyon-Seung Yi; Ashok Khatri; Thomas Dean; Makoto Okazaki; Thomas J Gardella; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-06-08       Impact factor: 6.741

Review 8.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

Review 9.  Epigenetics and obesity.

Authors:  Reinhard Stöger
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

Review 10.  Acrodysostosis syndromes.

Authors:  C Silve; C Le-Stunff; E Motte; Y Gunes; A Linglart; E Clauser
Journal:  Bonekey Rep       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.